Alaxia

Pioneering therapeutic advancements in respiratory health with an innovative antimicrobial solution targeting cystic fibrosis.

General Information
Company Name
Alaxia
Founded Year
2008
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology
Funding Stage
-
Social Media

Alaxia - Company Profile

Alaxia is a leading French biotech firm founded in 2008, dedicated to pioneering therapeutic advancements in respiratory health through its innovative antimicrobial solutions. The company specializes in creating therapeutic solutions for respiratory illnesses with a focus on cystic fibrosis using its unique peroxidase platform. Their flagship drug candidate, ALX-009, is designed to target even the most resilient bacterial strains associated with cystic fibrosis, offering a promising treatment option for this challenging condition.

Taxonomy: biotech firm, respiratory health, therapeutic advancements, cystic fibrosis, antimicrobial solution, peroxidase platform, drug candidate, innovative compound, French biotech, private company, respiratory diseases, bacterial strains, therapeutic solutions, resilient bacteria, ALX-009

Funding Rounds & Investors of Alaxia (0)

View All

There is no investment information

Latest News of Alaxia

View All

No recent news or press coverage available for Alaxia.

Similar Companies to Alaxia

View All
Chance Pharmaceuticals 畅溪制药 - Similar company to Alaxia
Chance Pharmaceuticals 畅溪制药 A clinical-stage biotech company focusing on discovering, developing and commercializing inhalation therapies.
Nordic Bioscience - Similar company to Alaxia
Nordic Bioscience Improving preclinical and clinical trial success rates with world-leading biomarkers & specialized laboratory services.
KlinEra Global Services - Similar company to Alaxia
KlinEra Global Services Customized Services, Global Reach.
Advaccine - Similar company to Alaxia
Advaccine Advancing Vaccines,Improving Immunotherapeutics
Inspira Pharmaceuticals Limited - Similar company to Alaxia
Inspira Pharmaceuticals Limited UK biotech focused on preclinical research for diseases of the respiratory tract